CQ2-20454-22752
4 vaccinations
7 coded responses
23 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 064 / CT
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-02-13
Registered in v-safe
- 2021-02-13
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Pain in extremity — Feeling: Good · Muscle or body achesFree text: Aching forearms, especially a few hours after 2nd dose. Symptom has diminished since.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Some bruises at injection sight and elsewhere on the same armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
-
2021-03-19
Survey response — day 28, dose 2MedDRA: Condition aggravated, Fatigue, Headache, Pain, Pre-existing disease, Restlessness, Sleep disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Restless Leg Syndrome worse than usual (every night rather than 1-2 nights per week and disrupting sleep. Headaches (could be seasonal allergies). Fatigue and body aches.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-04-02
-
2021-05-21
Survey response — 3 months, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Tinnitus slightly more noticeableMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-20
-
2021-11-15
Dose 3 — Pfizer-BioNTech
-
2022-02-19
Survey response — 12 months, dose 2MedDRA: Pain — Feeling: GoodFree text: persistent body aches (not debilitating, but new and/or unusualMedDRA releases: 2024-11 · check-in free text available
-
2022-06-11
Dose 4 — Pfizer-BioNTech
-
2022-06-28
Survey response — day 14, dose 4MedDRA: Pain — Feeling: GoodFree text: After 4th dose, unusual body aches and pains, but nothing that impaired daily functionMedDRA releases: 2024-11 · check-in free text available
- 2022-07-14
- 2022-07-17
- 2022-07-23
- 2022-12-11
-
2023-06-11
Survey response — 12 months, dose 4MedDRA: Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
| 4 | 2022-06-11 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Aching forearms, especially a few hours after 2nd dose. Symptom has diminished since.
Systemic reaction (other): Some bruises at injection sight and elsewhere on the same arm
Release 5 — day 28, dose 2
Symptoms: Restless Leg Syndrome worse than usual (every night rather than 1-2 nights per week and disrupting sleep. Headaches (could be seasonal allergies). Fatigue and body aches.
Release 8 — 3 months, dose 2
Symptoms: Tinnitus slightly more noticeable
Release 11 — 12 months, dose 2
Symptoms: persistent body aches (not debilitating, but new and/or unusual
Release 12 — day 14, dose 4
Symptoms: After 4th dose, unusual body aches and pains, but nothing that impaired daily function
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Restlessness | ○ | ✓ | ○ |
| SD | Sleep disorder | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release